David Abrams Abrams Capital Management
David Abrams is the founder of Abrams Capital Management, a Boston-based firm with a flexible value-oriented mandate. A former Baupost Group investor, he is known for concentrated positions and a willingness to hold cash or unconventional securities when public equities are unattractive. Abrams Capital’s filings are followed for high-conviction ideas across equities and special situations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLP
Cantaloupe
CTLP
|
+$21.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$78.8M |
| 2 |
Meta Platforms (Facebook)
META
|
+$4.24M |
| 3 |
Asbury Automotive
ABG
|
+$2.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 45.7% |
| 2 | Communication Services | 22.1% |
| 3 | Industrials | 15.31% |
| 4 | Energy | 7.03% |
| 5 | Financials | 6.13% |
Similar funds
David Abrams's Q1 2023 Portfolio in Review
As of Q1 2023, David Abrams held 16 positions worth $3.16B, up 13% from $2.8B the previous quarter. Its ten largest holdings account for 92% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 0%. David Abrams opened no new positions and made no exits, leaving the 16-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, down from 46% a quarter earlier, followed by Communication Services and Industrials.
- David Abrams added most to Cantaloupe in Q1 2023, an estimated $21.8M increase.
- David Abrams's biggest Q1 2023 reduction was Teva Pharmaceuticals, cutting an estimated $78.8M.
- David Abrams's ten largest holdings make up 92% of its $3.16B portfolio in Q1 2023.
- David Abrams opened 0 new positions and closed 0 in Q1 2023.
- David Abrams's portfolio value rose 13% quarter-over-quarter to $3.16B.
Based on Abrams Capital Management's 13F filing for Q1 2023, filed 12 May 2023.